WO2010047561A3 - Diagnostic kit for predicting the prognosis of invasive or non-muscle invasive bladder cancer, method for predicting the prognosis of bladder cancer, and bladder cancer medicine screening method - Google Patents
Diagnostic kit for predicting the prognosis of invasive or non-muscle invasive bladder cancer, method for predicting the prognosis of bladder cancer, and bladder cancer medicine screening method Download PDFInfo
- Publication number
- WO2010047561A3 WO2010047561A3 PCT/KR2009/006160 KR2009006160W WO2010047561A3 WO 2010047561 A3 WO2010047561 A3 WO 2010047561A3 KR 2009006160 W KR2009006160 W KR 2009006160W WO 2010047561 A3 WO2010047561 A3 WO 2010047561A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bladder cancer
- prognosis
- predicting
- invasive
- diagnostic kit
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Abstract
The present invention relates to a diagnostic kit for predicting the prognosis of invasive or non-muscle invasive bladder cancer, to a method for predicting the prognosis of bladder cancer, and to a bladder cancer medicine screening method. More particularly, the present invention relates to a diagnostic kit for predicting the prognosis of bladder cancer, comprising, as active ingredients, primer pairs, a probe, or an antibody for a gene-classifier which statistically analyzes gene expression among normal tissues and bladder cancer tissues by using a micro-array to predict the reoccurrence or progression of non-muscle invasive bladder cancer, or for a gene-classifier which may predict the progression of invasive bladder cancer, cancer-specific survival, or total survival. The present invention also relates to a method for predicting the prognosis of bladder cancer using the primer pairs, the probe, or the antibody. The method of the present invention predicts the prognosis of bladder cancer in an inexpensive, convenient, and quick manner, and is useful in screening bladder cancer medicine.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080104773A KR20100045703A (en) | 2008-10-24 | 2008-10-24 | Diagnosis kit for prognosis-prediction of invasive or non-muscle invasive bladder cancer, method for estimating prognosis of bladder cancer and method for screening therapeutic agent of bladder cancer |
KR10-2008-0104773 | 2008-10-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010047561A2 WO2010047561A2 (en) | 2010-04-29 |
WO2010047561A3 true WO2010047561A3 (en) | 2010-11-18 |
Family
ID=42119860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2009/006160 WO2010047561A2 (en) | 2008-10-24 | 2009-10-23 | Diagnostic kit for predicting the prognosis of invasive or non-muscle invasive bladder cancer, method for predicting the prognosis of bladder cancer, and bladder cancer medicine screening method |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20100045703A (en) |
WO (1) | WO2010047561A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101683961B1 (en) * | 2014-03-31 | 2016-12-07 | 동아대학교 산학협력단 | Recurrence Marker for Diagnosis of Bladder Cancer |
KR101750146B1 (en) * | 2014-12-30 | 2017-06-23 | 충북대학교 산학협력단 | Use of RSPH9 for Prognostic Marker Diagnosis of Bladder Cancer |
EP3333268A1 (en) * | 2016-12-09 | 2018-06-13 | Institut Paoli Calmettes | Biomarker panel for prognosis of bladder cancer |
-
2008
- 2008-10-24 KR KR1020080104773A patent/KR20100045703A/en not_active Application Discontinuation
-
2009
- 2009-10-23 WO PCT/KR2009/006160 patent/WO2010047561A2/en active Application Filing
Non-Patent Citations (4)
Title |
---|
EWISS ET AL.: "Gene expression profile in squamous cell carcinoma of the urinary bladder using complementary deoxyribonucleic acid microarray.", UROL. ONCOL., vol. 25, no. 2, 23 March 2007 (2007-03-23), pages 120 - 127 * |
GOTTARDO ET AL.: "MicroRNA profiling in kidney and bladder cancers", UROL. ONCOL., vol. 25, no. 5, 7 September 2007 (2007-09-07), pages 387 - 392 * |
KAWAKAMI ET AL.: "Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling", ONCOL. REP., vol. 16, no. 3, September 2006 (2006-09-01), pages 521 - 531 * |
KIM ET AL.: "Molecular biomarkers in urothelial bladder cancer", CANCER SCI., vol. 99, no. 4, 28 March 2008 (2008-03-28), pages 646 - 652 * |
Also Published As
Publication number | Publication date |
---|---|
KR20100045703A (en) | 2010-05-04 |
WO2010047561A2 (en) | 2010-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006135886A3 (en) | Compositions and methods for treating and diagnosing cancer | |
WO2006138275A3 (en) | Compositions and methods for treating and diagnosing cancer | |
WO2011015944A3 (en) | Use of free dna as an early predictor of severity in acute pancreatitis | |
WO2008115419A3 (en) | Gene expression markers for prediction of patient response to chemotherapy | |
WO2005084109A3 (en) | Cancer specific gene mh15 | |
WO2009037572A3 (en) | Biomarker combinations for colorectal cancer | |
MX2009013646A (en) | Methods of diagnosing and treating cancer. | |
ES2530843T3 (en) | MicroRNA based methods for the diagnosis of pancreatic cancer | |
NO20083461L (en) | Gene expression markers for colorectal cancer prognosis | |
EP3683320A3 (en) | Mirna fingerprint in the diagnosis of lung cancer | |
WO2005039382A3 (en) | Prediction of likelihood of cancer recurrence | |
WO2008100352A3 (en) | Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis | |
WO2008070301A3 (en) | Predicting lung cancer survival using gene expression | |
WO2009149026A3 (en) | Genomic approaches to fetal treatment and diagnosis | |
WO2009083950A3 (en) | Biomarkers for the prediction of renal injury | |
WO2007058968A3 (en) | Gene expression profiles and methods of use | |
EP2374884A3 (en) | Human miRNAs isolated from mesenchymal stem cells | |
WO2010051314A3 (en) | Genomic classification of non-small cell lung carcinoma based on patterns of gene copy number alterations | |
WO2008137693A3 (en) | Retinal flow cytometry | |
WO2012074904A3 (en) | Methods and systems for evaluating the sensitivity or resistance of tumor specimens to chemotherapeutic agents | |
WO2007114986A3 (en) | Cooperative probes and methods of using them | |
WO2010033773A3 (en) | Diagnostic, prognostic and therapeutic uses of mirs in adaptive pathways and/or disease pathways | |
WO2010028373A3 (en) | Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients | |
WO2008033427A3 (en) | Compositions and methods for detection of lysosomal storage disease | |
WO2011047058A3 (en) | Assay for the prediction of therapeutic effectiveness of mesenchymal stromal cells, and methods of using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09822237 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09822237 Country of ref document: EP Kind code of ref document: A2 |